Health care-associated pneumonia and community-acquired pneumonia: A single-center experience

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 10, 2007, Pages 3568-3573

  Micek, Scott T ^a   Kollef, Katherine E ^b   Reichley, Richard M ^c   Roubinian, Nareg ^b   Kollef, Marin H ^b  

^a BARNES JEWISH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BJC HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CULTURE MEDIUM; DIALYSIS; DRUG USE; FEMALE; HAEMOPHILUS INFLUENZAE; HEALTH CARE ASSOCIATED PNEUMONIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IATROGENIC DISEASE; IMMUNE DEFICIENCY; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS; NONHUMAN; NURSING HOME; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DATA INTERPRETATION, STATISTICAL; FEMALE; HOSPITAL MORTALITY; HOSPITALS, TEACHING; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; PNEUMONIA; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 34948846090     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00851-07     Document Type: Article

References (18)

1. Alvarez-Lerma, F. 1996. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med. 22:387-394.
2. Garnacho-Montero, J., J. L. Garcia-Garmendia, A. Barrero-Almodovar, F. J. Jimenez-Jimenez, C. Perez-Paredes, and C. Ortiz-Leyba. 2003. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit. Care Med. 31:2742-2751.
3. Harbarth, S., K. Ferriere, S. Hugonnet, B. Ricou, P. Suter, and D. Pittet. 2002. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch. Surg. 137:1353-1359.
4. Harbarth, S., J. Garbino, J. Pugin, J. A. Romand, D. Lew, and D. Pittet. 2003. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am. J. Med. 115:529-535.
5. Hospital-Acquired Pneumonia Guideline Committee of the American Thoracic Society and Infectious Diseases Society of America. 2005. Guidelines for the management of adults with hospital-acquired pneumonia, ventilator-associated pneumonia, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171:388-416.
6. Ibrahim, E. H., G. Sherman, S. Ward, V. J. Fraser, and M. H. Kollef. 2000. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146-155.
7. Ibrahim, E. H., S. Ward, G. Sherman, R. Schaiff, V. J. Fraser, and M. H. Kollef. 2001. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit. Care. Med. 29:1109-1115.
8. Kollef, M. H. 2000. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin. Infect. Dis. 31:S131-S138.
9. Kollef, M. H., G. Sherman, S. Ward, and V. J. Fraser. 1999. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462-474.
10. Kollef, M. H., A. Shorr, Y. P. Tabak, V. Gupta, L. Z Liu, and R. S. Johannes. 2005. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128: 3854-3862.
11. Kollef, M. H., and S. Ward. 1998. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 113:412-420.
12. Kumar, A., D. Roberts, K. E. Wood, B. Light, J. E. Parrillo, S. Sharma, R. Suppes, D. Feinstein, S. Zanotti, L. Taiberg, D. Gurka, A. Kumar, and M. Cheang. 2006. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med. 34:1589-1596.
13. Luna, C. M., P. Vujacich, M. S. Niederman, C. Vay, C. Gherardi, J. Matera, and E. C. Jolly. 1997. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111:676-685.
14. Mandell, L. A., J. G. Bartlett, S. F. Dowell, T. M. File, Jr., D. M. Musher, and C. Whitney. 2003. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin. Infect. Dis. 37:1405-1433.
15. Micek, S. T., A. E. Lloyd, D. J. Ritchie, R. M. Reichley, V. J. Fraser, and M. H. Kollef. 2005. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob. Agents Chemother. 49:1306-1311.
16. Micek, S. T., N. Roubinian, T. Heuring, M. Bode, J. Williams, C. Harrison, T. Murphy, D. Prentice, B. E. Ruoff, and M. H. Kollef. 2006. Before-after study of a standardized hospital order set for the management of septic shock. Crit. Care Med. 34:2707-2713.
17. Rello, J., M. Gallego, D. Mariscal, R. Sonora, and J. Valles. 1997. The value of routine microbial investigation in ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 156:196-200.
18. Schramm, G. E., J. A. Johnson, J. A. Doherty, S. T. Micek, S. T., and M. H. Kollef. 2006. Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment. Crit. Care Med. 34:2069-2074.